Table 3.
Groups | % Motility | Count (Mio/ml) | % Viability |
---|---|---|---|
Control | 52.86 | 50.68 ± 0.09 | 60.06 |
Viagra | 69.09* | 68.17 ± 0.07* | 66.80 |
ATB 50 | 56.22 | 58.11 ± 0.15 | 63.78 |
ATB 100 | 63.28* | 66.21 ± 0.12* | 68.40* |
ATB 200 | 68.71* | 72.04 ± 0.17* | 72.94* |
ATB 400 | 79.24* | 84.42 ± 0.21* | 77.38* |
Data are expressed as mean ± SD (n = 6). *P < 0.05 as compared to control group